Anna Kan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Liver Metastases

Radiofrequency Ablation

Top Venues

Technology in cancer research & treatment

Clinical cancer research : an official journal of the American Association for Cancer Research

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Hailong Chen, Huifang Li, Minke He, Zhicheng Lai, Lichang Huang, Dongsheng Wen, Ming Shi, Anna Kan
UBA2 SUMOylates NQO1 and promotes the proliferation of hepatocellular carcinoma by modulating the MAPK pathway. Cancer science (2024)
MinKe He, YeXing Huang, Zefeng Du, ZhiCheng Lai, Hanyue Ouyang, JingXian Shen, DongSheng Wen, Qi-Jiong Li, Yao-Jun Zhang, Wei Wei, MinShan Chen, Li Xu, Anna Kan, Ming Shi
Lenvatinib, toripalimab plus FOLFOX chemotherapy in hepatocellular carcinoma patients with extrahepatic metastasis: A biomolecular exploratory, phase II trial (LTSC). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Dong-Sheng Wen, Li-Chang Huang, Xiao-Yun Bu, Min-Ke He, Zhi-Cheng Lai, Ze-Feng Du, Ye-Xing Huang, Anna Kan, Ming Shi
DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinoma. Cell death & disease 14 (11) (2023)
YeXing Huang, LiHong Zhang, MinKe He, ZhiCheng Lai, XiaoYun Bu, DongSheng Wen, Qi-Jiong Li, Li Xu, Wei Wei, YaoJun Zhang, ZhongGuo Zhou, MinShan Chen, RongPing Guo, Ming Shi, Anna Kan
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials. Technology in cancer research & treatment 21 (2022)
YeXing Huang, LiHong Zhang, MinKe He, ZhiCheng Lai, XiaoYun Bu, DongSheng Wen, Qi-Jiong Li, Li Xu, Wei Wei, YaoJun Zhang, ZhongGuo Zhou, MinShan Chen, RongPing Guo, Ming Shi, Anna Kan
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials. Technology in cancer research & treatment 21 (2022)
Haijing Deng, Anna Kan, Ning Lyu, Meng He, Xin Huang, Shuang Qiao, Shaolong Li, Wenhua Lu, Qiankun Xie, Huiming Chen, Jinfa Lai, Qifeng Chen, Xiongying Jiang, Shousheng Liu, Zhenfeng Zhang, Ming Zhao
Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma. Journal for immunotherapy of cancer 9 (6) (2022)
YeXing Huang, LiHong Zhang, MinKe He, ZhiCheng Lai, XiaoYun Bu, DongSheng Wen, Qi-Jiong Li, Li Xu, Wei Wei, YaoJun Zhang, ZhongGuo Zhou, MinShan Chen, RongPing Guo, Ming Shi, Anna Kan
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials. Technology in cancer research & treatment 21 (2022)
YeXing Huang, LiHong Zhang, MinKe He, ZhiCheng Lai, XiaoYun Bu, DongSheng Wen, Qi-Jiong Li, Li Xu, Wei Wei, YaoJun Zhang, ZhongGuo Zhou, MinShan Chen, RongPing Guo, Ming Shi, Anna Kan
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials. Technology in cancer research & treatment 21 (2022)